skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 7,301  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A systematic methodology review of fluorescence-guided cancer surgery to inform the development of a core master protocol and outcome set
Material Type:
Article
Add to My Research

A systematic methodology review of fluorescence-guided cancer surgery to inform the development of a core master protocol and outcome set

BMC cancer, 2024-06, Vol.24 (1), p.697-697 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12386-4

Full text available

2
Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study
Material Type:
Article
Add to My Research

Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study

BMC cancer, 2022-02, Vol.22 (1), p.194-194, Article 194 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09303-y ;PMID: 35189858

Full text available

3
Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Material Type:
Article
Add to My Research

Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

BMC cancer, 2022-01, Vol.22 (1), p.112-112, Article 112 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09226-8 ;PMID: 35086517

Full text available

4
TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study
Material Type:
Article
Add to My Research

TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study

BMC cancer, 2024-06, Vol.24 (1), p.717-717 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12484-3

Full text available

5
Colorectal cancer liver metastases - a population-based study on incidence, management and survival
Material Type:
Article
Add to My Research

Colorectal cancer liver metastases - a population-based study on incidence, management and survival

BMC cancer, 2018-01, Vol.18 (1), p.78-78, Article 78 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3925-x ;PMID: 29334918

Full text available

6
Randomised phase II trial of trifluridine/tipiracil
Material Type:
Article
Add to My Research

Randomised phase II trial of trifluridine/tipiracil

BMC cancer, 2023-08, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11199-1

Full text available

7
The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study
Material Type:
Article
Add to My Research

The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study

BMC cancer, 2018-04, Vol.18 (1), p.476-476, Article 476 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-018-4353-2 ;PMID: 29699509

Full text available

8
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Material Type:
Article
Add to My Research

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

BMC cancer, 2023-02, Vol.23 (1), p.192-192, Article 192 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10662-3 ;PMID: 36849943

Full text available

9
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
Material Type:
Article
Add to My Research

Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

BMC cancer, 2023-02, Vol.23 (1), p.190-190, Article 190 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10666-z ;PMID: 36849899

Full text available

10
C/EBP[beta] expression decreases in cervical cancer and leads to tumorigenesis
Material Type:
Article
Add to My Research

C/EBP[beta] expression decreases in cervical cancer and leads to tumorigenesis

BMC cancer, 2023-01, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10543-9

Full text available

11
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
Material Type:
Article
Add to My Research

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

BMC cancer, 2022-11, Vol.22 (1), p.1224-1224, Article 1224 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10335-7 ;PMID: 36443715

Full text available

12
Anticancer traits of chimeric antigen receptors cells as novel approaches for melanoma treatment
Material Type:
Article
Add to My Research

Anticancer traits of chimeric antigen receptors cells as novel approaches for melanoma treatment

BMC cancer, 2022-11, Vol.22 (1) [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10320-0

Full text available

13
Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma
Material Type:
Article
Add to My Research

Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma

BMC cancer, 2024-06, Vol.24 (1), p.700-700 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12436-x

Full text available

14
Dose escalation of tolinapant in UK secondary care centres
Material Type:
Article
Add to My Research

Dose escalation of tolinapant in UK secondary care centres

BMC cancer, 2024-06, Vol.24 (1) [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12310-w

Full text available

15
The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers
Material Type:
Article
Add to My Research

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers

BMC cancer, 2024-06, Vol.24 (1), p.701-701 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12429-w

Full text available

16
A miRNA-disease association prediction model based on tree-path global feature extraction and fully connected artificial neural network with multi-head self-attention mechanism
Material Type:
Article
Add to My Research

A miRNA-disease association prediction model based on tree-path global feature extraction and fully connected artificial neural network with multi-head self-attention mechanism

BMC cancer, 2024-06, Vol.24 (1), p.683-683 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12420-5

Full text available

17
Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma
Material Type:
Article
Add to My Research

Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma

BMC cancer, 2024-06, Vol.24 (1), p.687-687 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12452-x

Full text available

18
Time-dependent efficacy analysis of first-line immunotherapies for advanced non-small cell lung cancer
Material Type:
Article
Add to My Research

Time-dependent efficacy analysis of first-line immunotherapies for advanced non-small cell lung cancer

BMC cancer, 2024-06, Vol.24 (1), p.684-684 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12439-8

Full text available

19
PPIH acts as a potential predictive biomarker for patients with common solid tumors
Material Type:
Article
Add to My Research

PPIH acts as a potential predictive biomarker for patients with common solid tumors

BMC cancer, 2024-06, Vol.24 (1), p.681-681 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12446-9

Full text available

20
Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis
Material Type:
Article
Add to My Research

Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis

BMC cancer, 2024-06, Vol.24 (1), p.678-678 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12462-9 ;PMID: 38831404

Full text available

Results 1 - 20 of 7,301  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2009  (191)
  2. 2009 To 2011  (675)
  3. 2012 To 2014  (437)
  4. 2015 To 2018  (2,014)
  5. After 2018  (3,984)
  6. More options open sub menu

Subject 

  1. Oncology  (6,771)
  2. Life Sciences & Biomedicine  (6,741)
  3. Science & Technology  (6,741)
  4. Humans  (5,325)
  5. Cancer  (3,748)
  6. Female  (3,399)
  7. Health Aspects  (3,039)
  8. Analysis  (2,877)
  9. Diagnosis  (2,783)
  10. Patients  (2,724)
  11. Middle Aged  (2,514)
  12. Male  (2,464)
  13. Cancer Therapies  (2,449)
  14. Tumors  (2,423)
  15. Chemotherapy  (2,338)
  16. Prognosis  (2,302)
  17. Metastasis  (2,272)
  18. Aged  (2,177)
  19. Patient Outcomes  (2,046)
  20. More options open sub menu

Language 

  1. Japanese  (842)
  2. French  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait